Literature DB >> 25185083

Regarding relative toxicities of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer.

Donald B Fuller1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25185083     DOI： 10.1200/JCO.2014.56.5572

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  1 in total

1.  Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.

Authors:  Joshua A Halpern; Art Sedrakyan; Wei-Chun Hsu; Jialin Mao; Timothy J Daskivich; Paul L Nguyen; Encouse B Golden; Josephine Kang; Jim C Hu
Journal:  Cancer       Date:  2016-05-25       Impact factor: 6.860
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.